← Scroll for more →
Chemomab Therapeutics Ltd. (CMMB)
Pharmaceutical Preparations
Latest Price
$1.19
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.13
P/B Ratio
9.41
Valuation metrics
adjust assumptions →EPS: $0.02
Book value / share: $0.33
Formula: √(22.5 × EPS × BVPS)
Graham Number
$0.37
69% downside
EPS: $0.02
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$0.27
77% downside
Institutional Ownership
0.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 95.3K | -- | 0.02% | +31.1K | 2026-06-30 |
| ADAR1 Capital Management, LLC | 80.0K | -- | 0.02% | -- | 2026-06-30 |
| Kestra Private Wealth Services, LLC | 61.7K | -- | 0.01% | -- | 2026-06-30 |
| Ikarian Capital, LLC | 51.8K | -- | 0.01% | -- | 2026-06-30 |
| Rhumbline Advisers | 30.5K | -- | 0.01% | +12.2K | 2026-06-30 |
| XTX Topco Ltd | 16.0K | -- | 0.00% | -2.6K | 2026-06-30 |
| Philadelphia Investment Partners, LLC | 15.0K | -- | 0.00% | +6.8K | 2026-06-30 |
| Lido Advisors, LLC | 14.3K | -- | 0.00% | -- | 2026-06-30 |
| BNP Paribas Financial Markets | 6.8K | -- | 0.00% | -1.6K | 2026-06-30 |
| GAMMA Investing LLC | 4.7K | -- | 0.00% | -2.8K | 2026-06-30 |